|
C13ORF27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.217670E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.315680E-02 |
| Normal-vs-Stage2 |
3.726000E-02 |
| Normal-vs-Stage3 |
1.313030E-01 |
| Normal-vs-Stage4 |
1.516160E-01 |
| Stage1-vs-Stage2 |
5.729200E-01 |
| Stage1-vs-Stage3 |
5.701800E-01 |
| Stage1-vs-Stage4 |
3.813000E-01 |
| Stage2-vs-Stage3 |
8.876000E-01 |
| Stage2-vs-Stage4 |
5.513200E-01 |
| Stage3-vs-Stage4 |
6.507000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.782500E-03 |
| Normal-vs-AfricanAmerican |
1.258070E-03 |
| Normal-vs-Asian |
7.045000E-01 |
| Caucasian-vs-AfricanAmerican |
1.057610E-01 |
| Caucasian-vs-Asian |
3.311400E-01 |
| AfricanAmerican-vs-Asian |
1.899640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.009500E-04 |
| Normal-vs-Female |
3.394800E-01 |
| Male-vs-Female |
5.361600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.780000E-01 |
| Normal-vs-Extreme_Weight |
2.285700E-02 |
| Normal-vs-Obese |
8.242700E-03 |
| Normal-vs-Extreme_Obese |
1.098790E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.502400E-01 |
| Normal_Weight-vs-Obese |
2.896800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.688400E-01 |
| Extreme_Weight-vs-Obese |
3.965600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.457400E-01 |
| Obese-vs-Extreme_Obese |
5.846000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.207600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.396300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.576200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.712250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.191800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.829000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.158800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.460360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.332200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80709999997308E-06 |
| Normal-VS-Type2 PRCC |
1.492160E-01 |
| Normal-VS-KIRP CIMP |
2.829900E-04 |
| Normal-VS-Unclassified PRCC |
7.726000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.738400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.67504999999402E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.615600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.611700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.961000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.143600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.004100E-02 |
| Normal-vs-N1 |
4.920400E-02 |
| Normal-vs-N2 |
5.419400E-04 |
| N0-vs-N1 |
2.825200E-01 |
| N0-vs-N2 |
2.140300E-02 |
| N1-vs-N2 |
8.078300E-02 |
|
|
